North American Vaccine Certiva
Executive Summary
FDA inspection of diphtheria, tetanus and pertussis vaccine facilities will begin by mid-May, company announces. FDA has told the company that the inspection and review of promotional materials are the only outstanding issues prior to approval. Certiva will be comarketed by Abbott